Detalhe da pesquisa
1.
Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
mSphere
; 3(4)2018 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-30135222